🇺🇸 FDA
Patent

US 6756033

Method for delivering benzindene prostaglandins by inhalation

expired A61KA61K31/5575A61K9/0078

Quick answer

US patent 6756033 (Method for delivering benzindene prostaglandins by inhalation) held by United Therapeutics Corporation expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/5575, A61K9/0078, A61P, A61P11/00